Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kolb

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's ContinuumA Feizpour, V Doré, J D Doecke, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 27, 2016
Extended interval dosing of natalizumab in multiple sclerosisL Zhovtis Ryerson, T C Frohman, J Foley, et al.
JAMA Neurology|February 10, 2025
Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based BiomarkersLawren VandeVrede, Hanna Cho, Mark Sanderson-Cimino, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 12, 2022
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivityStephen Zicha, Randall J Bateman, Leslie M Shaw, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2026
Visual versus quantitative tau-PET Braak staging in Alzheimer's disease using [<sup>18</sup>F]MK6240Arthur C Macedo, Karine Provost, Jean-Paul Soucy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 20, 2023
Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's diseaseJoseph Therriault, Stijn Servaes, Cécile Tissot, et al.
Scientific Reports|October 28, 2025
Equivalence of the FCSRT and RAVLT to detect medial Temporal lobe atrophy and tauopathyEtienne Aumont, Kelly Amiel, Delphine Oliva Lopez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 3, 2023
Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-β positive individualsMarcel S Woo, Cécile Tissot, Juan Lantero-Rodriguez, et al.
Ebiomedicine|November 5, 2024
Identification of late-stage tau accumulation using plasma phospho-tau217Marcel S Woo, Joseph Therriault, Erin M Jonaitis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJoão Pedro Ferrari-Souza, Guilherme Povala, Nesrine Rahmouni, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's ContinuumA Feizpour, V Doré, J D Doecke, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 27, 2016
Extended interval dosing of natalizumab in multiple sclerosisL Zhovtis Ryerson, T C Frohman, J Foley, et al.
JAMA Neurology|February 10, 2025
Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based BiomarkersLawren VandeVrede, Hanna Cho, Mark Sanderson-Cimino, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 12, 2022
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivityStephen Zicha, Randall J Bateman, Leslie M Shaw, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2026
Visual versus quantitative tau-PET Braak staging in Alzheimer's disease using [<sup>18</sup>F]MK6240Arthur C Macedo, Karine Provost, Jean-Paul Soucy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 20, 2023
Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's diseaseJoseph Therriault, Stijn Servaes, Cécile Tissot, et al.
Scientific Reports|October 28, 2025
Equivalence of the FCSRT and RAVLT to detect medial Temporal lobe atrophy and tauopathyEtienne Aumont, Kelly Amiel, Delphine Oliva Lopez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 3, 2023
Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-β positive individualsMarcel S Woo, Cécile Tissot, Juan Lantero-Rodriguez, et al.
Ebiomedicine|November 5, 2024
Identification of late-stage tau accumulation using plasma phospho-tau217Marcel S Woo, Joseph Therriault, Erin M Jonaitis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJoão Pedro Ferrari-Souza, Guilherme Povala, Nesrine Rahmouni, et al.
Pageof 21